Neurology Journal
Fecha de publicación: 5 May 2020
DOI: https://doi.org/10.1212/WNL.0000000000009431
Autores: Yuan Cheng, Yan-Jiang Wang
Background: Parkinson disease (PD) is a progressive neurodegenerative disorder of the motor system that affects 6.2 million people globally.1 The exact pathogenic mechanism underlying PD remains unclear. Although the current drugs for PD can relieve disease symptoms to some extent, the efficacy duration is limited, and it is hard to cure, halt, or reverse the disease.2 Therefore, the identification of modifiable risk factors is imperative for the prevention of PD.
